Latest Feature Article
Introducing the Illumina–University of Melbourne Genomics Hub
Positioning Australia at the forefront of healthcare innovation
Feature Articles
NextSeq 550Dx Approved for Clinical Use in China
Continued expansion of clinical products further advances precision medicine globally
Transforming Diagnoses and Care for Acute Myeloid Leukemia
Illumina supports program to bring NGS technology to Latin America
The New Workflow: How Labs Will Benefit from TSO 500 Updates
Innovative enhancements streamline enablement of in-house comprehensive genomic profiling
Accelerating Genomics: Astarte Medical Launches NICUtrition®
Illumina Accelerator graduate’s platform addresses unmet needs in neonatal intensive care
Press Releases
In the News
| Date | Publication | Title |
|---|---|---|
| Jan 13, 2021 | Clinical Lab Products | Myriad Genetics, Illumina Form Strategic Partnership in Oncology |
| Jan 13, 2021 | Clinical Lab Products | Illumina Partners with 4 Companies to Advance Genomic Profiling for Oncology |
| Jan 12, 2021 | Fierce Biotech | JPM: Illumina inks multiple cancer diagnostic partnerships to complement upcoming Grail acquisition |
| Jan 11, 2021 | GenomeWeb | Illumina CEO Discusses Pan-Cancer IVD Assay, CDx Collaborations at JP Morgan |
| Jan 11, 2021 | CNBC Closing Bell | Illumina CEO on 2021 outlook and tracking new coronavirus strains |
Additional Resources
Investor Information
Careers at Illumina
At Illumina, we push boundaries. We think beyond the conventional. We dream big. With the energy of so many bright and accomplished people, the opportunities are endless.
Search for JobsPress Contacts
If you are a member of the media:
- Email pr@illumina.com
- Tel. 858.882.6822
If you are not a member of the media, please visit Contact Us.